Delivering safe and timely cancer care during COVID‐19: lessons and successes from the transition period

The pandemic caused by Covid-19 has caused significant strain on healthcare professionals across the globe. Without downplaying the devastating effects of the virus itself, the collateral damage - specifically in cancer care- has only compounded an already difficult time in medicine [1]. Previously protected by cancer treatment targets, cancer patients across the country found their care halted by coronavirus as hospitals cancelled elective clinics and operating lists to redeploy staff.